cyc 202 has been researched along with arsenic in 2 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (arsenic) | Trials (arsenic) | Recent Studies (post-2010) (arsenic) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 27,806 | 280 | 13,049 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murakami, H | 1 |
| DeFuria, J; Shea, TB | 1 |
1 review(s) available for cyc 202 and arsenic
| Article | Year |
|---|---|
[New strategy for the treatment of multiple myeloma].
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Dexamethasone; Drug Design; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Multiple Myeloma; Oxides; Prognosis; Protease Inhibitors; Purines; Pyrazines; Roscovitine; Thalidomide; Transplantation Conditioning | 2005 |
1 other study(ies) available for cyc 202 and arsenic
| Article | Year |
|---|---|
Arsenic inhibits neurofilament transport and induces perikaryal accumulation of phosphorylated neurofilaments: roles of JNK and GSK-3beta.
Topics: Animals; Arsenic; Axons; Cells, Cultured; Chick Embryo; Environmental Pollutants; Enzyme Inhibitors; Epitopes; Ganglia, Spinal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; JNK Mitogen-Activated Protein Kinases; Mice; Neurites; Neuroblastoma; Neurofilament Proteins; Neurons; Neurotoxins; Phosphorylation; Purines; Roscovitine; Tumor Cells, Cultured | 2007 |